TACTICS: Final overall survival (OS) data from a randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients (pts) with hepatocellular carcinoma (HCC)

被引:27
作者
Kudo, Masatoshi [1 ]
Ueshima, Kazuomi [2 ]
Ikeda, Masafumi [3 ]
Torimura, Takuji [4 ]
Aikata, Hiroshi [5 ]
Izumi, Namiki [6 ]
Yamasaki, Takahiro [7 ]
Hino, Keisuke [8 ]
Kuzuya, Teiji [9 ]
Isoda, Norio [10 ]
Yasui, Kohichiroh [11 ]
Aino, Hajime [12 ]
Ido, Akio [13 ]
Kawabe, Naoto [14 ]
Nakao, Kazuhiko [15 ]
Wada, Yoshiyuki [16 ]
Yoshimura, Kenichi [17 ]
Okusaka, Takuji [18 ]
Furuse, Junji [19 ]
Arai, Yasuaki [20 ]
机构
[1] Kindai Univ, Fac Med, Osaka, Japan
[2] Kindai Univ, Fac Med, Osakasayama, Japan
[3] Natl Canc Ctr Hp East, Kashiwa, Chiba, Japan
[4] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
[5] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan
[6] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[7] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[8] Kawasaki Med Sch, Okayama, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan
[10] Jichi Med Univ, Shimono, Japan
[11] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan
[12] Social Insurance Tagawa Hosp, Div Gastroenterol, Dept Med, Tagawa, Japan
[13] Kagoshima Univ Hosp, Dept Gastroenterol, Kagoshima, Japan
[14] Fujita Hlth Univ, Sch Med, Dept Liver Biliary Tract & Pancreas Dis, Toyoake, Aichi, Japan
[15] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki, Japan
[16] Natl Hosp Org Kyushu Med Ctr, Fukuoka, Japan
[17] Kyoto Univ Hosp, Translat Res Ctr, Kyoto, Japan
[18] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[19] Kyorin Univ, Fac Med, Tokyo, Japan
[20] Natl Canc Ctr, Tokyo, Japan
关键词
D O I
10.1200/JCO.2021.39.3_suppl.270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
270
引用
收藏
页数:4
相关论文
empty
未找到相关数据